Metraipolis › archive › dc_09e44835a18b
ELISPOT as a Functional for Biomarker Study in Cancer Immunotherapy: Applications and Future Directions — Europe PMC PMID:42123631
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42123631
- DOI
- 10.3390/ijms27094056
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T01:18:52.388Z
- SHA-256 of the archived text
c3650cb68f137b8a681b36b92a39ff3e8b092b232a8b7c75a5120e93f6d10dde- Stable URL of this page
https://metraipolis.com/documento/dc_09e44835a18b
How to cite
ELISPOT as a Functional for Biomarker Study in Cancer Immunotherapy: Applications and Future Directions — Europe PMC PMID:42123631 — Europe PMC (en), https://europepmc.org/article/MED/42123631 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_09e44835a18b (Metraipolis archive dc_09e44835a18b, sha256 c3650cb68f137b8a681b36b92a39ff3e8b092b232a8b7c75a5120e93f6d10dde)
BibTeX
@misc{dc09e44835a18b,
title = {ELISPOT as a Functional for Biomarker Study in Cancer Immunotherapy: Applications and Future Directions — Europe PMC PMID:42123631},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42123631},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_09e44835a18b; sha256 c3650cb68f137b8a681b36b92a39ff3e8b092b232a8b7c75a5120e93f6d10dde},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42123631. Agents can read the archived copy with the MCP tool read_document.